These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2830067)

  • 1. Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion.
    Słowińska-Srzednicka J; Puciłowska J; Zgliczyński S
    Clin Exp Hypertens A; 1987; 9(11):1843-58. PubMed ID: 2830067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
    Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats.
    Barrett RJ; Wright KF; Taylor DR; Proakis AG
    Life Sci; 1987 Apr; 40(15):1499-506. PubMed ID: 2951574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
    Sala C; Morganti A; Ferraris P; Ardeleani G; Venegoni P; Quorso P; Ambrosi B; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(4):S336-8. PubMed ID: 2977175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
    Nishida S; Matsuki M; Adachi N; Horino M; Yoneda M; Endoh M; Oyama H; Kikuoka M; Otsuka R; Ishii R
    J Clin Endocrinol Metab; 1987 May; 64(5):995-1001. PubMed ID: 3031125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.
    Rossitto G; Maiolino G; Lenzini L; Bisogni V; Seccia TM; Cesari M; Iacobone M; Rossi GP
    Surgery; 2018 Apr; 163(4):789-795. PubMed ID: 29198769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat.
    Sowers JR; Sollars EG; Tuck ML; Asp ND
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):598-603. PubMed ID: 6997889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dopaminergic control of aldosterone secretion in man (author's transl)].
    Suzuki H; Kasai K; Naitoh T; Nakamura T; Shina H; Ieiri T; Takemura Y; Shimoda S
    Nihon Naibunpi Gakkai Zasshi; 1980 Jul; 56(7):973-82. PubMed ID: 7007104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic regulation of aldosterone secretion: how credible?
    Ganguly A
    Clin Sci (Lond); 1984 Jun; 66(6):631-7. PubMed ID: 6327138
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
    Krishna GG; Chusid P; Hoeldtke RD
    Nephron; 1987; 47(3):184-9. PubMed ID: 3683686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis.
    Bernardi M; De Palma R; Trevisani F; Malatesta R; Baraldini M; Cursaro C; Gasbarrini G
    Clin Sci (Lond); 1988 Feb; 74(2):137-43. PubMed ID: 3338258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
    Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
    J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of disturbance of the secretion of prolactin in patients with acromegaly].
    Avakian MR; Marova EI; Dobracheva AD; Pankova SS; Bobrovskaia TA
    Probl Endokrinol (Mosk); 1988; 34(5):24-8. PubMed ID: 3217383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of aldosterone secretion?
    McDougall JG; Scoggins BA; Butkus A; Coghlan JP; Denton DA; Fei DT; Hardy KJ; Wright RD
    J Endocrinol; 1981 Nov; 91(2):271-80. PubMed ID: 7299326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responses of plasma aldosterone, cortisol and adrenocorticotropin to two dopamine receptor antagonists.
    Staessen J; Fiocchi R; Bouillon R; Fagard R; Lijnen P; Lissens W; Amery A
    Methods Find Exp Clin Pharmacol; 1985 Oct; 7(10):523-7. PubMed ID: 3001453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.